Home
About Us
Company Profile
Capability
Capacity
Arch Service
Cell Culture Media
CDMO Service
Corporate R&D Center
News
Join Us
CN
EN
Arch Service
AI prediction and development platform
Antibody discovery and engineering platform
Innovative linker payload andconjugation development platform
Pharmacological efficacy and pharmacokinetic evaluationplatform
Druggability evaluation platform
Early research sample preparation and cell line construction platform
Structure and function characterization & New formulation development platform
Innovative complex molecules design and development platform
Antibody discovery and engineering platform
Antibody discovery and engineering modification strategy
Hybridoma screening
Phage screening
Humanization
Affinity maturation
Fc Silence Modification
Enhanced ADCC modification
Enhanced ADCP modification
Enhanced CDC modification
Extended Half-life modification (Fc amino acid mutation)
Extended half-life modification (with Anti-HSA VHH)
Fc heteropairing modification (Fc mutation)
Conjugate site modification (new Cys mutation)
Conjugate site modification (Sortase recognition peptide)
N-glycosylation site removal
Hot spots removal
Hydrophobic cluster modification
Charge cluster modification
Aggregation property modification
High Viscosity Property Modification
Hybridoma screening and humanization of mouse antibodies
Phage display screening and mutation library screening modification
FC Engineering